FAQ: Quantum BioPharma's Investor Webinar and Unbuzzd Wellness Partnership
Summary
What is the main topic of the investor webinar hosted by Unbuzzd Wellness?
The webinar will outline the current Reg D 506(c) investment opportunity, review clinical data, and highlight strategies to accelerate sales of unbuzzd™, a beverage designed to accelerate alcohol metabolism and reduce hangover symptoms. It features company leadership including CEO John Duffy and Medical Director Dr. Eric Hoskins.
When and where is the Unbuzzd Wellness investor webinar taking place?
The webinar is scheduled for September 16, 2025, at 1:30 p.m. PT / 4:30 p.m. ET. It is a virtual event, accessible online, though specific registration details are not provided in the content.
Who is involved in hosting and presenting at the webinar?
The webinar features Unbuzzd Wellness CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David. Quantum BioPharma is the licensor and partial owner of Unbuzzd Wellness.
What is unbuzzd™ and what are its claimed benefits?
unbuzzd™ is a scientifically proven beverage designed to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms. It is developed by Quantum BioPharma and licensed to Unbuzzd Wellness for over-the-counter sales.
What is Quantum BioPharma’s relationship with Unbuzzd Wellness?
Quantum BioPharma invented unbuzzd™ and licensed it to Unbuzzd Wellness (formerly Celly Nutrition Corp.), retaining 20.11% ownership as of March 31, 2025. Quantum also receives royalty payments of 7% of sales up to $250 million, then 3% in perpetuity, and keeps rights for pharmaceutical versions.
What are the key focus areas of Quantum BioPharma’s broader business?
Quantum BioPharma focuses on neurodegenerative and metabolic disorders and alcohol misuse, with assets like Lucid-MS for multiple sclerosis. They also maintain strategic investments through subsidiary FSD Strategic Investments Inc., involving loans secured by property.
Where can investors find more information about Quantum BioPharma and updates?
The latest news and updates are available in the company’s newsroom at https://ibn.fm/QNTM. The full press release for this webinar can be viewed at https://ibn.fm/Xp5a2.
Why is this webinar significant for potential investors?
It presents a Reg D 506(c) investment opportunity, provides clinical data reviews, and discusses sales acceleration strategies, offering insights into the growth potential of unbuzzd™ and Quantum BioPharma’s licensing model.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 207671